Clinical Trials Directory

Trials / Conditions / Recurrent or Metastatic Nasopharyngeal Carcinoma

Recurrent or Metastatic Nasopharyngeal Carcinoma

8 registered clinical trials studyying Recurrent or Metastatic Nasopharyngeal Carcinoma — 6 currently recruiting.

StatusTrialSponsorPhase
RecruitingA Study of YL201 in Combination With Toripalimab and With or Without Cisplatin in Nasopharyngeal Carcinoma.
NCT07258979
MediLink Therapeutics (Suzhou) Co., Ltd.Phase 1 / Phase 2
RecruitingCombination Therapy for PD-1 Resistant Recurrent or Metastatic Nasopharyngeal Carcinoma: A Bayesian Adaptive P
NCT07070479
Ming-Yuan ChenPhase 2
RecruitingA Study of MRG003 in Combination With Pucotenlimab Versus Chemotherapy in the Treatment of Patients With Recur
NCT06976190
Shanghai Miracogen Inc.Phase 3
RecruitingIrinotecan Liposome Combined with S-1 in PD-1/L1 Inhibitor Refractory Recurrent or Metastatic NPC
NCT06657690
Sun Yat-sen UniversityPhase 2
RecruitingClinical Study of Mitoxantrone Hydrochloride Liposome Combined with PD-1 Blockade in Recurrent or Metastatic N
NCT06472713
Ming-Yuan ChenPhase 2
RecruitingA Multi-center, Randomized, Double-blind, Phase II/III Clinical Trial of AK104 or Placebo in Combination With
NCT06241599
Sun Yat-sen UniversityPhase 2 / Phase 3
Active Not RecruitingA Study to Evaluate the Efficacy and Safety of MRG003 in Patients With Recurrent Metastatic Nasopharyngeal Car
NCT05126719
Shanghai Miracogen Inc.Phase 2
CompletedToripalimab and Anlotinib Combination Treatment in Patients With Recurrent or Metastatic Nasopharyngeal Carcin
NCT04996758
Sun Yat-sen UniversityPhase 2